AHR and Abdominal obesity: Since exposure to environmental PAHs can cause insulin resistance, abdominal obesity (Lee et al., 2011) and leukopenia (Lan et al., 2004), too, one might attribute the adverse effects of clozapine—probably in synergy with other AhR ligands—to AhR activation.